Praxis Precision Medicines to Present at Upcoming Investor Conferences
14 mai 2021 09h00 HE
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference
08 mars 2021 08h30 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...
TLC to Present at Upcoming Virtual Investor Conferences
02 mars 2021 04h00 HE
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 02, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
Misonix to Participate in Upcoming March Investor Conferences
01 mars 2021 08h07 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Conformis, Inc. to Participate in Upcoming Investor Conferences
25 févr. 2021 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
aTyr Pharma to Present at March Investor Conferences
25 févr. 2021 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
12 févr. 2021 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
11 févr. 2021 16h01 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
Los Alamos History Museum Provides Immersive Experience - Virtually and In-Person
29 oct. 2020 17h00 HE
|
Los Alamos
Los Alamos, NM, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Los Alamos, New Mexico—where discoveries are made—is well known for its storied past, dating back to a series of volcanic eruptions 1.6 million...
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
28 oct. 2020 18h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...